TENDU-1

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTENDU-1
Drug Alias NameB cell-T cell conjugate (Immuneed)peptide conjugate vaccine (Ultimovacs)[MTTE]3-LSP vaccine (Immuneed)TENDU-1[MTTE]3-CMV
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNorway
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmuneed AB
China Registration ClassN/A

Develop Information

Active CompaniesUltimovacs As
Inactive CompaniesImmuneed AB
Active IndicationsProstatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A